Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of GT200300185ApublicationCriticalpatent/GT200300185A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA I EN LA QUE R1,R2,R3,R4, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON DE UTILIDAD EN EL FENOMENO DEL CRECIMIENTO CELULAR ANORMAL, TAL COMO EL CANCER YA QUE SON INHIBIDORES DE LAS TIROSINAQUINASAS.THE PRESENT INVENTION REFERS TO COMPOUNDS OF FORMULA IN WHICH R1, R2, R3, R4, ARE FUNCTIONAL GROUPS DESCRIBED IN THE RECORD. THESE COMPOUNDS ARE USEFUL IN THE PHENOMENON OF ABNORMAL CELLULAR GROWTH, SUCH AS CANCER AS THEY ARE INHIBITORS OF THYROSINAQUINASES.
GT200300185A2002-08-282003-08-28
NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS
GT200300185A
(en)